Laura B. Ramsey

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

Laura B. Ramsey, Samuel G. Johnson, Kelly E. Caudle et al. · Clinical Pharmacology & Therapeutics · 2014 · 440 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad Bousman, James M. Stevenson, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2023 · 403 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Clinical Pharmacogenetics Implementation Consortium Guideline for <i>SLCO1B1</i>, <i>ABCG2</i>, and <i>CYP2C9</i> genotypes and Statin‐Associated Musculoskeletal Symptoms

Rhonda M. Cooper‐DeHoff, Mikko Niemi, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2022 · 331 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

Russell A. Wilke, Laura B. Ramsey, Samuel G. Johnson et al. · Clinical Pharmacology & Therapeutics · 2012 · 327 citations · Full text

Medicine, Molecular Medicine, Pharmacology +11

Rare versus common variants in pharmacogenetics: <i>SLCO1B1</i> variation and methotrexate disposition

Laura B. Ramsey, Gitte Hoffmann Bruun, Wenjian Yang et al. · Genome Research · 2011 · 260 citations · Full text

Life Sciences, Genetics, Pharmacology +17